RSV, influenza, and COVID-19: Gearing up for the threat of a 'triple epidemic'

Expanding peripartum prophylaxis could be more cost-effective, but would likely lead to significant over-treatment.

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

The newly FDA-approved prescription product delivers nalmefene to the nasal cavity to reverse the effects of opioid overdose.

Scott Kober sits down with Dr. Joseph Domachowske, Professor of Pediatrics, Professor of Microbiology and Immunology, and Director of the Global Maternal-Child and Pediatric Health Program at the SUNY Upstate Medical University.

This formulation of ibuprofen is the only non-opioid product approved to treat pain in infants that is delivered through injection, according to Cumberland Pharmaceuticals.

The once-daily topical cream for the treatment of atopic dermatitis (AD) has demonstrated positive topline results in 2 phase 3 studies in adults and children aged 2 years and up. According to Dermavant, a supplemental new drug application (sNDA) filed with the FDA is anticipated in Q1 of 2024.